Severe Hemophilia B

Severe Hemophilia B is the indication for 2 drugs in DrugBank. It is covered by 6 curated, structured indications.

Also known as: Severe Haemophilia B · Hemophilia B, Severe
Classified under: Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Hemic and Lymphatic Diseases
Mutations
Signs, Symptoms, and General Pathologies
Vascular Diseases
Indicated drugs: Etranacogene dezaparvovec
Fidanacogene elaparvovec

Resolves to

Vocabularies

SNOMED CT1336093007UMLSC5679576

What you can answer from here — as of October 25, 2026

2Indicated drugsWith each drug's targets and mechanism

Listed above

6Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

3Clinical trialsPhase, status and sponsor resolved per trial

Which approved drugs for Severe Hemophilia B share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.